(0.32%) 5 116.17 points
(0.38%) 38 386 points
(0.35%) 15 983 points
(-0.07%) $82.57
(1.53%) $2.06
(-0.70%) $2 341.20
(-1.54%) $27.24
(-0.34%) $958.20
(0.18%) $0.934
(0.35%) $11.02
(0.15%) $0.797
(0.01%) $93.31
2 days till quarter result
(amc 2024-05-02)
Expected move: +/- 5.74%
Live Chart Being Loaded With Signals
Safeguard Scientifics, Inc. no longer investing. It is a private equity and venture capital firm specializing in expansion financings, growth capital, management buyouts, recapitalizations, industry consolidations, corporate spinouts, growth stage, and early stage financings...
Stats | |
---|---|
Šios dienos apimtis | 899 343 |
Vidutinė apimtis | 77 932.00 |
Rinkos kapitalizacija | 7.54M |
EPS | $0 ( 2024-03-07 ) |
Kita pelno data | ( $0 ) 2024-05-02 |
Last Dividend | $1.000 ( 2019-12-20 ) |
Next Dividend | $0 ( N/A ) |
P/E | -0.722 |
ATR14 | $0.0920 (12.27%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-01-30 | Manko Joseph M. Jr. | Buy | 38 087 | Common Stock, $0.10 par value |
2024-01-30 | Demont Ross D | Buy | 20 775 | Common Stock |
2024-01-30 | Michelson Beth | Buy | 22 506 | Common Stock |
2024-01-30 | Glass Russell D | Buy | 20 775 | Common Stock |
2024-01-01 | Dow Mark | Buy | 0 |
INSIDER POWER |
---|
49.26 |
Last 96 transactions |
Buy: 1 657 002 | Sell: 456 103 |
Tūris Koreliacija
Safeguard Scientifics Inc Koreliacija
10 Labiausiai teigiamai susiję koreliacijos |
---|
10 Labiausiai neigiamai susiję koreliacijos |
---|
Ar žinojote?
Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).
Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.
Safeguard Scientifics Inc Koreliacija - Valiuta/Žaliavos
Safeguard Scientifics Inc Finansinės ataskaitos
Annual | 2023 |
Pajamos: | $2.04M |
Bruto pelnas: | $2.04M (100.00 %) |
EPS: | $-0.610 |
FY | 2023 |
Pajamos: | $2.04M |
Bruto pelnas: | $2.04M (100.00 %) |
EPS: | $-0.610 |
FY | 2022 |
Pajamos: | $-3.30M |
Bruto pelnas: | $-3.30M (100.00 %) |
EPS: | $-1.140 |
FY | 2021 |
Pajamos: | $0.00 |
Bruto pelnas: | $0.00 (0.00 %) |
EPS: | $1.299 |
Financial Reports:
No articles found.
Safeguard Scientifics Inc Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
First Dividend | $2.70 | 1997-07-03 |
Last Dividend | $1.000 | 2019-12-20 |
Next Dividend | $0 | N/A |
Payout Date | 2019-12-30 | |
Next Payout Date | N/A | |
# dividends | 3 | -- |
Total Paid Out | $5.58 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 0.23 | -- |
Div. Sustainability Score | 0.130 | |
Div.Growth Potential Score | 0 | |
Div. Directional Score | 0 | -- |
Year | Amount | Yield |
---|---|---|
1997 | $2.70 | 4.50% |
1998 | $1.876 | 2.92% |
1999 | $0 | 0.00% |
2000 | $0 | 0.00% |
2001 | $0 | 0.00% |
2002 | $0 | 0.00% |
2003 | $0 | 0.00% |
2004 | $0 | 0.00% |
2005 | $0 | 0.00% |
2006 | $0 | 0.00% |
2007 | $0 | 0.00% |
2008 | $0 | 0.00% |
2009 | $0 | 0.00% |
2010 | $0 | 0.00% |
2011 | $0 | 0.00% |
2012 | $0 | 0.00% |
2013 | $0 | 0.00% |
2014 | $0 | 0.00% |
2015 | $0 | 0.00% |
2016 | $0 | 0.00% |
2017 | $0 | 0.00% |
2018 | $0 | 0.00% |
2019 | $1.000 | 11.70% |
2020 | $0 | 0.00% |
2021 | $0 | 0.00% |
2022 | $0 | 0.00% |
2023 | $0 | 0.00% |
2024 | $0 | 0.00% |
The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
LOMA | Dividend Knight | 2023-06-30 | Quarterly | 2 | 5.23% | 8.53 |
PHK | Dividend Royal | 2023-11-10 | Monthly | 22 | 6.88% | 8.50 |
JQC | Dividend Royal | 2023-11-14 | Monthly | 22 | 6.56% | 8.50 |
PCF | Dividend King | 2023-12-18 | Monthly | 38 | 7.05% | 8.50 |
PVL | Dividend King | 2023-11-15 | Monthly | 14 | 9.37% | 8.50 |
NCV | Dividend Royal | 2024-02-09 | Monthly | 22 | 7.68% | 8.50 |
SBR | Dividend Royal | 2023-11-14 | Monthly | 38 | 7.74% | 8.50 |
MTR | Dividend Diamond | 2023-10-30 | Monthly | 39 | 10.10% | 8.50 |
PDI | Dividend Royal | 2023-11-10 | Monthly | 13 | 7.86% | 8.50 |
ZTR | Dividend King | 2024-02-09 | Monthly | 37 | 8.35% | 8.50 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | -8.16 | 1.500 | -10.00 | -10.00 | [0 - 0.5] |
returnOnAssetsTTM | -0.531 | 1.200 | -10.00 | -10.00 | [0 - 0.3] |
returnOnEquityTTM | -0.441 | 1.500 | -6.01 | -9.01 | [0.1 - 1] |
payoutRatioTTM | 0 | -1.000 | 0 | 0 | [0 - 1] |
currentRatioTTM | 4.84 | 0.800 | 10.00 | 8.00 | [1 - 3] |
quickRatioTTM | 4.64 | 0.800 | 10.00 | 8.00 | [0.8 - 2.5] |
cashRatioTTM | 4.64 | 1.500 | 10.00 | 10.00 | [0.2 - 2] |
debtRatioTTM | 0.0547 | -1.500 | 9.09 | -10.00 | [0 - 0.6] |
interestCoverageTTM | -2.47 | 1.000 | -2.03 | -2.03 | [3 - 30] |
operatingCashFlowPerShareTTM | -0.205 | 2.00 | -0.0682 | -0.136 | [0 - 30] |
freeCashFlowPerShareTTM | -0.205 | 2.00 | -0.102 | -0.205 | [0 - 20] |
debtEquityRatioTTM | 0.0625 | -1.500 | 9.75 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 1.000 | 1.000 | 10.00 | 10.00 | [0.2 - 0.8] |
operatingProfitMarginTTM | -3.82 | 1.000 | -10.00 | -10.00 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | -2.65 | 1.000 | -10.00 | -10.00 | [0.2 - 2] |
assetTurnoverTTM | 0.0651 | 0.800 | -2.90 | -2.32 | [0.5 - 2] |
Total Score | 0.130 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | -0.607 | 1.000 | -0.162 | 0 | [1 - 100] |
returnOnEquityTTM | -0.441 | 2.50 | -3.86 | -9.01 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | -0.205 | 2.00 | -0.0682 | -0.205 | [0 - 30] |
dividendYielPercentageTTM | 76.92 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | -0.205 | 2.00 | -0.0682 | -0.136 | [0 - 30] |
payoutRatioTTM | 0 | 1.500 | 0 | 0 | [0 - 1] |
pegRatioTTM | -0.00982 | 1.500 | -3.40 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | -2.23 | 1.000 | -10.00 | 0 | [0.1 - 0.5] |
Total Score | -1.519 |
Safeguard Scientifics Inc
Safeguard Scientifics, Inc. no longer investing. It is a private equity and venture capital firm specializing in expansion financings, growth capital, management buyouts, recapitalizations, industry consolidations, corporate spinouts, growth stage, and early stage financings. It initially invests in a Series A-C round and opportunistically in a seed round. The firm prefers to make investments in companies engaged in the technology, financial services, and healthcare sector. Within the technology sector, it invests in software as a service, adtech / digital media, Internet of Everything, enhanced security, predictive analytics, machine learning, artificial intelligence, enterprise software, technology enabled services, internet/new media, financial technology, cloud, mobile, social, big data, in memory, and selected business services with capital requirements of up to $25 million. Within healthcare sector, the firm invests in molecular and point-of-care diagnostics, medical devices, regenerative medicine, medical technology, digital health, healthcare technology, specialty pharmaceuticals, and selected healthcare services. It invests throughout the United States with a focus on Mid-Atlantic region, and Southeastern Canada. The firm primarily invests between $5 million and $25 million in growth equity financing and between $5 million and $10 million in early-stage financing. It typically invests in the capital structures including owner financed and bootstrapped companies, corporate division or business unit, and venture capital-backed seeking a growth partner. The firm prefers to be the largest shareholder in its portfolio companies, with ownership in the range of 20 percent to 50 percent. However, it may occasionally take a majority or smaller stake in its portfolio companies. It prefers to invest in companies having proprietary technology and intellectual property. The firm prefers to take a Board seat in its portfolio companies. The company was founded in 1953 as Lancaster Corporation and changed its name to Safeguard Scientifics, Inc. in 1981. Safeguard Scientifics, Inc. is based in Radnor, Pennsylvania with additional office in Weston, Massachusetts.
Apie Signalai gyvai
Šiame puslapyje pateikti tiesioginiai signalai padeda nustatyti, kada PIRKTI ar PARDUOTI NA. Signalai vėluoja 1 minutę; kaip ir su visais rinkos signalais, taip ir su šiais, visuomet yra klaidų tikimybė.
Tiesioginiai prekybos signalai nėra apibrėžti, todėl getagraph.com neprisiima atsakomybės už jokius veiksmus, kurių buvo imtasi žinant šiuos signalus, kaip aprašyta Naudojimo sąlygose. Signalai yra pagrįsti įvairiais techninės analizės rodikliais.